Fundraising FoxExerkine
1 known investors
Find your way into Exerkine
Sign up to see every warm intro you have to Exerkine
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Exerkine team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Exerkine develops nutra-pharmaceutical therapies that target mitochondrial function to address both rare genetic disorders and age-related acquired conditions, with products spanning muscle function, cognition, metabolic health, and aging. It also offers formulation development, clinical research, regulatory guidance, private label manufacturing, and product strategy services, and markets a consumer supplement brand.
Founders & leadership
MT
Mark TarnopolskyFounder
Investors · 1
Frequently asked questions
- What does Exerkine do?
- Exerkine develops nutra-pharmaceutical therapies that target mitochondrial function to address both rare genetic disorders and age-related acquired conditions, with products spanning muscle function, cognition, metabolic health, and aging. It also offers formulation development, clinical research, regulatory guidance, private label manufacturing, and product strategy services, and markets a consumer supplement brand.
- Who are Exerkine's investors?
- Exerkine's investors include FHS Capital.